ClinVar

Description

This variant is denoted RAD51C c.716T>A at the cDNA level, p.Val239Glu (V239E) at the protein level, and results in the change of a Valine to a Glutamic Acid (GTG>GAG). This variant has not, to our knowledge, been published in the literature as pathogenic or benign. RAD51C Val239Glu was not observed in approximately 6,500 individuals of European and African American ancestry in the NHLBI Exome Sequencing Project, suggesting it is not a common benign variant in these populations. Since Valine and Glutamic Acid differ in polarity, charge, size or other properties, this is considered a non-conservative amino acid substitution. RAD51C Val239Glu occurs at a position where amino acids with properties similar to Valine are tolerated across species and is located in Walker B box in the ATP binding motif (Miller 2004). In silico analyses predict that this variant is probably damaging to protein structure and function. Based on currently available evidence, it is unclear whether RAD51C Val239Glu is a pathogenic or benign variant. We consider it to be a variant of uncertain significance.